Skip to main content
. 2021 Nov 11;11:22037. doi: 10.1038/s41598-021-01549-z

Figure 5.

Figure 5

Immunogenicity study of Vi-ΔVP8* for anti-ΔVP8*. (A) IgG of mice immunized with ΔVP8* or Vi-ΔVP8* conjugates. (B) percentage contribution of IgG subclasses to total IgG against ΔVP8*. (C) Neutralization analysis of sera from immunized mice; Day 42 immune sera for titers were used. BALB/c mice were immunized S.C. with 5 μg of Vi-ΔVP8*-P[4], P[6] or P[8], or 15 μg of multivalent formulation based on Vi polysaccharide, 3 times at 2-week intervals as described in Methods. Data were analyzed and illustrated using GraphPad Prism 6.0 software (GraphPad, https://graphpad.com); data are mean±s.d.; two sample t-test; *P<0.05, **P<0.01, *** P<0.001.